Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CytoDyn Inc. | 574,385 | reported | 20 Mar 2026 | tx 4+2,359,718 |
| SELLAS Life Sciences Group, Inc. | 115,577 | reported | 01 Jun 2016 | tx 15+453,525−253,750 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Mar 2026 | GRANT_AWARD | CytoDyn Inc. | 574,385 | 0.00 USD | deriv |
| 28 Oct 2024 | GRANT_AWARD | CytoDyn Inc. | 800,000 | 0.00 USD | deriv |
| 03 Jan 2024 | GRANT_AWARD | CytoDyn Inc. | 800,000 | 0.00 USD | deriv |
| 06 Sept 2022 | GRANT_AWARD | CytoDyn Inc. | 185,333 | 0.00 USD | deriv |
| 01 Jun 2016 | EXERCISE | SELLAS Life Sciences Group, Inc. | 31,250 | 1.75 USD | |
| 01 Jun 2016 | EXERCISE | SELLAS Life Sciences Group, Inc. | 65,625 | 1.85 USD | |
| 01 Jun 2016 | EXERCISE | SELLAS Life Sciences Group, Inc. | 30,000 | 1.71 USD | |
| 01 Jun 2016 | SALE | SELLAS Life Sciences Group, Inc. | 126,875 | 2.18 USD | |
| 01 Jun 2016 | EXERCISE | SELLAS Life Sciences Group, Inc. | 31,250 | 0.00 USD | deriv |
| 01 Jun 2016 | EXERCISE | SELLAS Life Sciences Group, Inc. | 30,000 | 0.00 USD | deriv |
| 01 Jun 2016 | EXERCISE | SELLAS Life Sciences Group, Inc. | 65,625 | 0.00 USD | deriv |
| 31 Dec 2014 | OTHER | SELLAS Life Sciences Group, Inc. | 3,846 | 1.28 USD | |
| 16 Jan 2015 | GRANT_AWARD | SELLAS Life Sciences Group, Inc. | 125,000 | 0.00 USD | deriv |
| 30 Jun 2014 | OTHER | SELLAS Life Sciences Group, Inc. | 2,461 | 2.60 USD | |
| 31 Dec 2013 | OTHER | SELLAS Life Sciences Group, Inc. | 2,728 | 1.88 USD | |
| 26 Nov 2013 | GRANT_AWARD | SELLAS Life Sciences Group, Inc. | 150,000 | 0.00 USD | deriv |
| 30 Jun 2013 | OTHER | SELLAS Life Sciences Group, Inc. | 1,369 | 1.35 USD | |
| 31 Dec 2012 | OTHER | SELLAS Life Sciences Group, Inc. | 1,246 | 1.30 USD | |
| 29 Jan 2013 | GRANT_AWARD | SELLAS Life Sciences Group, Inc. | 40,000 | 0.00 USD | deriv |